• We are sorry, but NCBI web applications do not support your browser and may not function properly. More information
Logo of pnasPNASInfo for AuthorsSubscriptionsAboutThis Article
Proc Natl Acad Sci U S A. Jun 1989; 86(12): 4731–4735.
PMCID: PMC287347

Identification of a high-virulence clone of type III Streptococcus agalactiae (group B Streptococcus) causing invasive neonatal disease.

Abstract

Chromosomal genotypes of 128 isolates of six serotypes (Ia, Ib, Ic, II, Ic/II, and III) of Streptococcus agalactiae (group B Streptococcus) recovered predominantly from human infants in the United States were characterized by an analysis of electrophoretically demonstrable allelic profiles at 11 metabolic enzyme loci. Nineteen distinctive electrophoretic types (ETs), representing multilocus clonal genotypes, were identified. Mean genetic diversity per locus among ETs of isolates of the same serotype was, on average, nearly equal to that in all 19 ETs. Cluster analysis of the ETs revealed two primary phylogenetic divisions at a genetic distance of 0.65. A single clone (ET 1) represented by 40 isolates expressing type III antigen formed division I. Division II was composed of 18 ETs in three major lineages diverging from one another at distances greater than 0.35 and included strains of all six antigenic classes. The type III organisms in division I produce more extracellular neuraminidase and apparently are more virulent than the type III strains in division II, which are related to strains of other serotypes that cause disease much less frequently. The existence of this unusually virulent clone accounts, in major part, for the high morbidity and mortality associated with infection by type III organisms.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (1.1M), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Baker CJ, Kasper DL. Group B streptococcal vaccines. Rev Infect Dis. 1985 Jul-Aug;7(4):458–467. [PubMed]
  • Jensen NE. Epidemiological aspects of human/animal interrelationship in GBS. Antibiot Chemother (1971) 1985;35:40–48. [PubMed]
  • Dillon HC, Jr, Khare S, Gray BM. Group B streptococcal carriage and disease: a 6-year prospective study. J Pediatr. 1987 Jan;110(1):31–36. [PubMed]
  • Lancefield RC, McCarty M, Everly WN. Multiple mouse-protective antibodies directed against group B streptococci. Special reference to antibodies effective against protein antigens. J Exp Med. 1975 Jul 1;142(1):165–179. [PMC free article] [PubMed]
  • Summary of the workshop on perinatal infections due to group B Streptococcus. J Infect Dis. 1977 Jul;136(1):137–152. [PubMed]
  • Lütticken R. The genetics of GBS. Antibiot Chemother (1971) 1985;35:71–82. [PubMed]
  • Selander RK, Musser JM, Caugant DA, Gilmour MN, Whittam TS. Population genetics of pathogenic bacteria. Microb Pathog. 1987 Jul;3(1):1–7. [PubMed]
  • Straus DC, Mattingly SJ, Milligan TW, Doran TI, Nealon TJ. Protease production by clinical isolates of type III group B streptococci. J Clin Microbiol. 1980 Sep;12(3):421–423. [PMC free article] [PubMed]
  • Milligan TW, Straus DC, Mattingly SJ. Extracellular neuraminidase production by group B streptococci. Infect Immun. 1977 Oct;18(1):189–195. [PMC free article] [PubMed]
  • Milligan TW, Baker CJ, Straus DC, Mattingly SJ. Association of elevated levels of extracellular neuraminidase with clinical isolates of type III group B streptococci. Infect Immun. 1978 Sep;21(3):738–746. [PMC free article] [PubMed]
  • Mattingly SJ, Milligan TW, Pierpont AA, Straus DC. Extracellular neuraminidase production by clinical isolates of group B streptococci from infected neonates. J Clin Microbiol. 1980 Oct;12(4):633–635. [PMC free article] [PubMed]
  • Doran TI, Straus DC, Mattingly SJ. Factors influencing release of type III antigens by group B streptococci. Infect Immun. 1981 Feb;31(2):615–623. [PMC free article] [PubMed]
  • Durham DL, Mattingly SJ, Doran TI, Milligan TW, Straus DC. Correlation between the production of extracellular substances by type III group B streptococcal strains and virulence in a mouse model. Infect Immun. 1981 Nov;34(2):448–454. [PMC free article] [PubMed]
  • Nealon TJ, Mattingly SJ. Association of elevated levels of cellular lipoteichoic acids of group B streptococci with human neonatal disease. Infect Immun. 1983 Mar;39(3):1243–1251. [PMC free article] [PubMed]
  • Yeung MK, Mattingly SJ. Biosynthetic capacity for type-specific antigen synthesis determines the virulence of serotype III strains of group B streptococci. Infect Immun. 1984 May;44(2):217–221. [PMC free article] [PubMed]
  • Nealon TJ, Mattingly SJ. Kinetic and chemical analyses of the biologic significance of lipoteichoic acids in mediating adherence of serotype III group B streptococci. Infect Immun. 1985 Oct;50(1):107–115. [PMC free article] [PubMed]
  • Maurer JJ, Mattingly SJ. In vitro method to differentiate isolates of type III Streptococcus agalactiae from symptomatic and asymptomatic patients. J Clin Microbiol. 1988 Apr;26(4):686–691. [PMC free article] [PubMed]
  • Selander RK, Caugant DA, Ochman H, Musser JM, Gilmour MN, Whittam TS. Methods of multilocus enzyme electrophoresis for bacterial population genetics and systematics. Appl Environ Microbiol. 1986 May;51(5):873–884. [PMC free article] [PubMed]
  • Terleckyj B, Willett NP, Shockman GD. Growth of several cariogenic strains of oral streptococci in a chemically defined medium. Infect Immun. 1975 Apr;11(4):649–655. [PMC free article] [PubMed]
  • Ochman H, Whittam TS, Caugant DA, Selander RK. Enzyme polymorphism and genetic population structure in Escherichia coli and Shigella. J Gen Microbiol. 1983 Sep;129(9):2715–2726. [PubMed]
  • Olyhoek T, Crowe BA, Wall RA, Achtman M. Comparison of clonal analysis and DNA restriction analysis for typing of Neisseria meningitidis. Microb Pathog. 1988 Jan;4(1):45–51. [PubMed]
  • Musser JM, Kroll JS, Moxon ER, Selander RK. Clonal population structure of encapsulated Haemophilus influenzae. Infect Immun. 1988 Aug;56(8):1837–1845. [PMC free article] [PubMed]
  • Musser JM, Kroll JS, Moxon ER, Selander RK. Evolutionary genetics of the encapsulated strains of Haemophilus influenzae. Proc Natl Acad Sci U S A. 1988 Oct;85(20):7758–7762. [PMC free article] [PubMed]
  • Caugant DA, Levin BR, Orskov I, Orskov F, Svanborg Eden C, Selander RK. Genetic diversity in relation to serotype in Escherichia coli. Infect Immun. 1985 Aug;49(2):407–413. [PMC free article] [PubMed]
  • Achtman M, Heuzenroeder M, Kusecek B, Ochman H, Caugant D, Selander RK, Väisanen-Rhen V, Korhonen TK, Stuart S, Orskov F, et al. Clonal analysis of Escherichia coli O2:K1 isolated from diseased humans and animals. Infect Immun. 1986 Jan;51(1):268–276. [PMC free article] [PubMed]
  • Caugant DA, Mocca LF, Frasch CE, Frøholm LO, Zollinger WD, Selander RK. Genetic structure of Neisseria meningitidis populations in relation to serogroup, serotype, and outer membrane protein pattern. J Bacteriol. 1987 Jun;169(6):2781–2792. [PMC free article] [PubMed]
  • Musser JM, Rapp VJ, Selander RK. Clonal diversity in Haemophilus pleuropneumoniae. Infect Immun. 1987 May;55(5):1207–1215. [PMC free article] [PubMed]
  • Hartl DL, Dykhuizen DE. The population genetics of Escherichia coli. Annu Rev Genet. 1984;18:31–68. [PubMed]
  • Achtman M, Pluschke G. Clonal analysis of descent and virulence among selected Escherichia coli. Annu Rev Microbiol. 1986;40:185–210. [PubMed]
  • Ferrieri P. GBS enzymes, hemolysin, toxins and other products. Antibiot Chemother (1971) 1985;35:57–70. [PubMed]
  • Rubens CE, Wessels MR, Heggen LM, Kasper DL. Transposon mutagenesis of type III group B Streptococcus: correlation of capsule expression with virulence. Proc Natl Acad Sci U S A. 1987 Oct;84(20):7208–7212. [PMC free article] [PubMed]
  • Weiser JN, Rubens CE. Transposon mutagenesis of group B streptococcus beta-hemolysin biosynthesis. Infect Immun. 1987 Sep;55(9):2314–2316. [PMC free article] [PubMed]
  • Anthony BF, Okada DM. The emergence of group B streptococci in infections of the newborn infant. Annu Rev Med. 1977;28:355–369. [PubMed]
  • Mayon-White RT. The incidence of GBS disease in neonates in different countries. Antibiot Chemother (1971) 1985;35:17–27. [PubMed]

Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences

Formats:

Related citations in PubMed

See reviews...See all...

Cited by other articles in PMC

See all...

Links

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...